FY 2025-26 final dividend of ₹1.20 per share disbursed; some payouts withheld over KYC/bank details
Final dividend of ₹1.20 per equity share of ₹10 each for FY 2025-26 has been disbursed.
By ScoutQuest · · 2 min read
- Final dividend per share
- ₹1.20 per equity share of ₹10 each for FY 2025-26
- Record date
- September 17, 2026
- Disbursement completed
- October 9, 2026
Dividend for FY 2025-26 disbursed
Bal Pharma has informed the stock exchanges that it has completed the disbursement of the final dividend of ₹1.20 per equity share of ₹10 each for the financial year 2025-26. The dividend was approved by the members at the 39th Annual General Meeting held on Thursday, September 24, 2026, and the disbursement was completed on October 9, 2026.
Who received the dividend
- Shareholders whose names appeared in the Register of Members or in the records of the depositories as on the record date, September 17, 2026
- The dividend was remitted through electronic modes including NACH, NECS and direct bank remittance, wherever valid bank account details were available
Shareholders are asked to verify the credit of the final dividend in their bank accounts and to check Form 26AS/AIS or the income tax e-update portal for details of tax deducted at source on the dividend, wherever applicable.
Where the dividend was withheld
- Physical shareholders whose mandatory KYC details or bank account particulars are incomplete or have not been updated with the Registrar and Transfer Agent, MUFG Intime India Private Limited
- Demat shareholders whose dividend could not be credited because bank account details are invalid or the bank account is blocked or closed
The amounts that could not be disbursed have been deposited into the company's bank account designated for this purpose. Amounts remaining unpaid after the expiry of 30 days from the date of declaration are to be transferred to the company's Unpaid Dividend Account within the statutory period, in line with Section 124 of the Companies Act, 2013.
What affected shareholders can do
- Physical shareholders: submit Forms ISR-1 (KYC details such as PAN, address, bank particulars, mobile number, email ID, with self-attested Aadhaar card, PAN card copy and Client Master List if holding a demat account; for joint holdings, PAN and Aadhaar of all joint shareholders) and ISR-2 (banker attestation of signature with cancelled cheque or bank statement) to the RTA for release of withheld dividend for FY 2025-26 and previous financial years
- Form ISR-3 is for opting out of nomination and Form SH-13 for updation of nomination
- Demat shareholders: update bank account details with the respective Depository Participant and, where necessary, inform the company or the RTA so the updated particulars are reflected and the payment can be processed
The company has said it is taking the necessary steps to facilitate the release of the withheld dividend upon receipt and verification of the requisite KYC and bank account documents.
IEPF
Dividend amounts pertaining to shares already transferred to the Investor Education and Protection Fund account will be transferred to the prescribed IEPF account, and the details of such transfers will also be available on the company's website.
For help
Shareholders needing assistance on KYC updation or dividend payments can contact the company at investors@balpharma.com or the RTA at investor.helpdesk@in.mpms.mufg.com.
More numbers
- Final dividend per equity share for FY 2025-26₹1.20
- Face value per equity share₹10
- Period after declaration for transfer to Unpaid Dividend Account30 days
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.